# STAR-PAK Study: Evaluating the Safety and Efficacy of PAK® (Paclitaxel Coated Balloon) in Treating Atherosclerotic Femoro-Popliteal Lesions

Study · id `cardio:ct-nct06734221` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06734221](<https://clinicaltrials.gov/study/NCT06734221>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06734221

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.

## Technical summary

Registry record NCT06734221. Allocation not applicable; no masking; primary purpose treatment. Start 2024-09-15 (actual); primary completion 2026-09-15 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT06734221, source copy `cardio:ctgov-nct06734221-2024-12-16`, retrieved 2026-10-31)
- Started: 2024-09-15 (actual) (ClinicalTrials.gov record NCT06734221, source copy `cardio:ctgov-nct06734221-2024-12-16`, retrieved 2026-10-31)
- Primary completion: 2026-09-15 (anticipated) (ClinicalTrials.gov record NCT06734221, source copy `cardio:ctgov-nct06734221-2024-12-16`, retrieved 2026-10-31)
- Completion: 2026-09-15 (anticipated) (ClinicalTrials.gov record NCT06734221, source copy `cardio:ctgov-nct06734221-2024-12-16`, retrieved 2026-10-31)
- Countries: Poland; Spain (ClinicalTrials.gov record NCT06734221, source copy `cardio:ctgov-nct06734221-2024-12-16`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06734221-2024-12-16`, retrieved 2026-10-31)

## The registry's words

- Brief title: STAR-PAK Study: Evaluating the Safety and Efficacy of PAK® (Paclitaxel Coated Balloon) in Treating Atherosclerotic Femoro-Popliteal Lesions
- Acronym: STAR-PAK
- Condition: Popliteal Artery Stenosis Above the Knee
- Condition: Peripheral Artery Disease
- Condition: Superficial Femoral Artery Stenosis
- Intervention (Device): Paclitaxel Coated Peripheral Angioplasty Balloon Catheter
- Lead sponsor: Balton Sp.zo.o.
- Lead sponsor class: INDUSTRY
- Collaborator: KCRI
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Balton Sp.zo.o. (`cardio:org-balton-sp-zo-o`)

## Provenance

Content hash: c885f57aada8b9c2d403fcaad9dc3c326a7e2ca1d54cae866c5e69f621ab894c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
